TScan shares jump ~15% with FDA go-ahead to begin cancer drug trials
Grandparents/iStock Editorial via Getty Images TScan Therapeutics (NASDAQ:TCRX) said the US Food and Drug Administration (FDA) has approved its investigational ...
Tag: TScan
Recommended.
